Archive - December 2021
FDA Approves Illuccix (gallium Ga 68 gozetotide) for Prostate Cancer Imaging
Intra-Cellular Therapies Announces U.S. FDA Approval of Caplyta (lumateperone) for the Treatment of Bipolar Depression in Adults
FDA Approves Otezla (apremilast) for the Treatment of Adult Patients with Plaque Psoriasis, Regardless of Severity Level
FDA Approves Two New Indications for Xarelto (rivaroxaban) to Help Prevent and Treat Blood Clots in Pediatric Patients
Tezspire approved in US for severe asthma
US prefers mRNA COVID-19 vaccines over J&J
Positive CHMP opinion for finerenone as new treatment for chronic kidney disease and type 2 diabetes
Xeris Biopharma’s glucagon injection becomes available in UK